Your browser doesn't support javascript.
loading
Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
Peyrot, Mark; Rubin, Richard R.
Afiliação
  • Peyrot M; Department of Sociology, Loyola College in Maryland, Baltimore, 21210-2699, USA. mpeyrot@loyola.edu
Diabetes Technol Ther ; 11(1): 57-62, 2009 Jan.
Article em En | MEDLINE | ID: mdl-19132857
BACKGROUND: A 16-week, two-site study evaluated outcomes for a new device (the Paradigm 722 System, Medtronic MiniMed, Northridge, CA) that combines a "smart" continuous subcutaneous insulin infusion (CSII) pump with real-time (RT) continuous glucose monitoring (CGM) and CareLinktrade mark data management software (DMS). METHODS: CSII-naive adults with type 1 diabetes in suboptimal control (mean glycosylated hemoglobin [A1C] = 8.6%) were randomized to the control arm, consisting of multiple daily injections (MDI) and self-monitoring of blood glucose (SMBG), or the study arm (CSII with RT-CGM as an adjunct to SMBG). Participants (n = 28) completed the validated Insulin Delivery System Rating Questionnaire (IDSRQ) and the parallel Blood Glucose (BG) Monitoring System Rating Questionnaire (BGMSRQ) at study start and end. Participants in the study arm (n = 14) also completed newly developed User Acceptance Questionnaires (UAQs) for CSII, RT-CGM, and DMS at study end. RESULTS: A1C reduction from study start to end was significant (P < 0.05) in both arms (-1.7% for study arm;-1.0% for control arm); there was no significant change in weight in either arm. The IDSRQ showed significantly (P < 0.05) greater benefit for the study arm in convenience, acceptability of BG monitoring requirements, BG control efficacy, diabetes worries, and interpersonal hassles, as well as higher overall satisfaction/preference. The BGMSRQ showed significantly (P < 0.05) greater benefit for the study arm in the BG monitoring system's ability to help manage glycemic control and less interest in changing to another BG monitoring system. The Study Arm UAQs showed positive ratings of system features. CONCLUSIONS: Several patient-reported outcomes were significantly more positive in the study arm than the control arm; none was significantly more positive in the control arm. The features of the integrated RT-CGM/CSII system were frequently used and highly rated by participants, with high user satisfaction.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Sistemas de Infusão de Insulina / Aceitação pelo Paciente de Cuidados de Saúde / Monitorização Ambulatorial / Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Diabetes Technol Ther Assunto da revista: ENDOCRINOLOGIA / TERAPEUTICA Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Sistemas de Infusão de Insulina / Aceitação pelo Paciente de Cuidados de Saúde / Monitorização Ambulatorial / Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Diabetes Technol Ther Assunto da revista: ENDOCRINOLOGIA / TERAPEUTICA Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Estados Unidos